Quant Biomarkers Company ^None

Quant Biomarkers Company specializes in the quantitative assessment of biomarkers related to human longevity and the development of personalized biomarker panels for aging and oncology. The company uses AI and technology to create financial products and analytics linked to biological age and supports investment de-risking in various sectors. Its main goal is to create a personalized assessment approach that supports interventions and Longevity Medicine therapeutic modalities. Additionally, the company serves as an incubator, IP accelerator, and investment vehicle for the Longevity Biomarkers sector, acquiring the most prospective start-ups, teams, and R&D facilities in the industry for the development of Longevity Preventive Medicine and Precision Health products as well as financial and analytical services.